DFTX
Definium Therapeutics, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$35.28
+7.00%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-38.5%
Return on equity
-31.8%
Return on assets
-23.8%
Return on invested capital
0.00x
Asset turnover
-$166.9M
Cash from operations
$8.07
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026